Results 31 to 40 of about 53,302 (297)

Botulinum toxin type B micromechanosensor [PDF]

Proceedings of the National Academy of Sciences, 2003
Botulinum neurotoxin (BoNT) types A, B, E, and F are toxic to humans; early and rapid detection is essential for adequate medical treatment. Presently available tests for detection of BoNTs, although sensitive, require hours to days. We report a BoNT-B sensor whose properties allow detection of BoNT-B within minutes.
W, Liu, Vedrana, Montana, Edwin R, Chapman, U, Mohideen, Vladimir, Parpura   +4 more
openaire   +2 more sources

Can Botulinum toxin type A prevent kinetic horizontal forehead lines to become static ? A five year follow up study [PDF]

Ain-Shams Journal of Surgery, 2013
Background:  Botulinum  toxin type A injection  has become a worldwide  leading  method for treating facial rhytides specially in women. Authors still debate whether or not regular administration of the toxin may delay or prevent kinetic horizontal ...
Asser EI-Hilaly, Sameh M EI-Taher, Ahmed F EISherief   +2 more
doaj   +1 more source

The impact of SARS-Cov-2 infection on the periocular injection pain and hypersensitive reaction to botulinum toxin type A: results from clinical questionnaires

Frontiers in Cellular and Infection Microbiology, 2023
BackgroundThe COVID-19 pandemic has brought about significant changes in the medical field, yet the use of botulinum toxin type A has remained uninterrupted.
Xiangyu Liu, Yanli Tian, Chanyuan Jiang, Miao Dong, Ming Li, Hefeng Sun, Xuefeng Han, Facheng Li   +7 more
doaj   +1 more source

Intralesional Injection of Botulinum Toxin Type A Compared with Intralesional Injection of Corticosteroid for the Treatment of Hypertrophic Scar and Keloid: A Systematic Review and Meta-Analysis

Medical Science Monitor, 2019
Background The optimal treatment for hypertrophic scar and keloid remains controversial. Therefore, the aim of this systematic review and meta-analysis was to compare the effectiveness of intralesional injection of botulinum toxin type A compared with ...
Minglei Bi, P. Sun, Danyi Li, Zheng Dong, Zhenyu Chen   +4 more
semanticscholar   +1 more source

Double Sandwich ELISA Modified Method for the Detection of Clostridium Botulinum Type E [PDF]

Journal of Fasa University of Medical Sciences, 2013
Background & Objective: A very small amount of botulinum toxin can cause death and on the other hand, there is no cure for its poison other than antitoxin.
Mohammad Ebrahim minaei, Mojtaba Saadati
doaj   +1 more source

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder

IJU Case Reports, 2022
Introduction We report a case of deterioration of bladder compliance after botulinum toxin type A injection and discontinuation of medication for overactive bladder.
Naoki Wada, Mayumi Ishikawa, Masaya Nagabuchi, Shogo Makino, Kotona Miyauchi, Noriyuki Abe, Hidehiro Kakizaki   +6 more
doaj   +1 more source

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis

Toxins
Botulinum toxin type-A (BoNT-A) has emerged as a key therapeutic agent for the management of spasticity. This paper presents a comprehensive bibliometric and visual analysis of research concerning BoNT-A treatment of spasticity to elucidate current ...
Salvatore Facciorusso, S. Spina, A. Picelli, A. Baricich, Gerard E. Francisco, Franco Molteni, Jörg Wissel, A. Santamato   +7 more
semanticscholar   +1 more source

Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity

Acta Médica Portuguesa, 2020
Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin ...
Alexandre Camões- Barbosa, Inês Mendes Ribeiro, Luisa Medeiros   +2 more
doaj   +1 more source

Botulinum Toxin Type B vs Type A in Cervical Dystonia: A Meta - analysis of high quality trials

Acta Neurológica Colombiana, 2012
Introduction: cervical dystonia (CD) is a frequent disabling condition. Botulinum Toxin (BT) type A is effective for CD. BT type B is an alternative, but its use for patients who develop neutralizing antibodies against BT type A is debatable ...
Diana M. Prada G
doaj   +2 more sources

Sarcopenia, Cerebral Palsy, and Botulinum Toxin Type A.

JBJS Reviews, 2019
Sarcopenia is common in both the elderly and children with cerebral palsy.Children with cerebral palsy have muscles that are much smaller than muscles in typically developing peers.Injections of botulinum toxin type A (BoNT-A) result in acute muscle ...
Iqbal Multani, J. Manji, M. Tang, W. Herzog, Jason J. Howard, H. Graham   +5 more
semanticscholar   +1 more source